CRVO stock results show that CervoMed missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. More
Articles
3 Stocks Gearing Up to Finish 2024 With a Bang
High-potential stocks are in the spotlight after a strong start to the year. Here's a look at three companies poised to end the year strong. More
Robotaxi Rally: Baidu (BIDU) Stock Pops as Apollo Go Orders Climb
The renewed interest in Baidu may not be short-lived. More
Apple’s AI Dilemma: 3 Chinese Stocks That Could Fill the Gap
Apple is reportedly seeking an partner to power Apple Intelligence over in the Chinese market. These Chinese AI stocks look worthy. More
3 Safe Stocks to Buy for Uncertain Markets: July Edition
Procter & Gamble, Coca Cola and Waste Management are the 3 best safe stocks to buy for uncertain market in July 2024. More
Albemarle (ALB) Stock Alert: Why Are Lithium Prices Plunging?
Albemarle (ALB) stock tumbled 9% yesterday after two banks cut their price targets on the lithium producer. More
3 Artificial Intelligence Stocks Set to Mint New Millionaires
Not all artificial intelligence stocks are created equal. Check out three stocks with Wall Street's darlings for your best bets. More